Sana Health Advances Toward Global Scale in Pain and PTSD Care

In this Health Moonshot Update, Unity Stoakes sits down with StartUp Health community member Richard Hanbury of Sana Health just prior to a major regulatory milestone: an FDA De Novo grant for neuropathic pain, creating a new class of audio-visual neuromodulation. Hanbury shares the decades-long journey behind Sana Health’s science, why neuropathic pain is the strategic wedge for broader mental health adoption, and how pivotal data showed a 78% reduction in gabapentinoid use in the active group. The conversation also explores Sana’s growing PTSD research with the US Department of Defense and Veterans Affairs, expanding studies in Israel, and why multimodal care is essential to the future of scalable pain and mental healthcare.